CNP Pharma GmbH's corporate purpose is the development, manufacture and distribution of pharmaceutical products. In the financial statements as of 30 June 2021 the company reports sales revenue of EUR 2,674,153.36 and current assets of EUR 3,140,116.01. Equity amounts to EUR 233,409.90, provisions totaled EUR 766,961.00 and liabilities amounted to EUR 2,139,745.11. The company had an average of 3 employees, is included in the consolidated financial statements of MIP Pharma Holding GmbH and was sold to capiton AG on 10 November 2020; a new management team has led the group since the takeover.
Entwicklung, Herstellung und Vertrieb pharmazeutischer Produkte
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Passau Local Court, HRB 7359 (as of 21 September 2026)
Source: German Commercial Register (Handelsregister) Passau Local Court, HRB 7359 (as of 21 September 2026)
Source: German Commercial Register (Handelsregister) Passau Local Court, HRB 7359 (as of 21 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Passau Local Court, HRB 7359 (as of 21 September 2026)
PB Pharma GmbH
Meerbusch · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
easycare Research GmbH
Merzig · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
BioNTech Innovative Manufacturing Services GmbH
Idar-Oberstein · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
